Inventor · disambiguated record
Remy Burcelin
Also filed as: BURCELIN REMY · BURCELIN RÉMY
7 granted patents·23 pending applications·25 citations·filing 2003–2023
77Inventor score
Top patents by PatentIndex Score
30 records- 0187US9259447B2Lactic acid bacteria and bifidobacteria for treating endotoxemiaBURCELIN RÉMY·Filed 2010·Granted Feb 16, 2016·19 cites·14 claims
- 0277US2023248786A1Bifidobacteria for treating diabetes and related conditionsDUPONT NUTRITION BIOSCI APS·Filed 2022·Application pending·0 cites
- 0377US2024335485A1Bifidobacteria for treating cardiac conditionsDUPONT NUTRITION BIOSCI APS·Filed 2023·Application pending·0 cites
- 0475US2014348796A1Bifidobacteria for treating diabetes and related conditionsDUPONT NUTRITION BIOSCI APS·Filed 2014·Application pending·0 cites
- 0575US2021322491A1Bifidobacteria for treating diabetes and related conditionsDUPONT NUTRITION BIOSCI APS·Filed 2021·Application pending·0 cites
- 0673US2022339215A1Bifidobacteria for treating cardiac conditionsDUPONT NUTRITION BIOSCI APS·Filed 2022·Application pending·0 cites
- 0768US2019307815A1Bifidobacteria for treating diabetes and related conditionsDUPONT NUTRITION BIOSCI APS·Filed 2018·Application pending·0 cites
- 0867US7618951B2Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetesAGRONOMIQUE INST NAT RECH·Filed 2003·Granted Nov 17, 2009·6 cites·5 claims
- 0966US2020316144A1Bifidobacteria for treating diabetes and related conditionsDUPONT NUTRITION BIOSCI APS·Filed 2020·Application pending·0 cites
- 1066US2020306322A1Bifidobacteria for treating cardiac conditionsDUPONT NUTRITION BIOSCI APS·Filed 2020·Application pending·0 cites
- 1164US2015320808A1Bifidobacteria for treating cardiac conditionsDUPONT NUTRITION BIOSCI APS·Filed 2015·Application pending·0 cites
- 1262US2018021391A1Bifidobacteria for treating diabetes and related conditionsDUPONT NUTRITION BIOSCI APS·Filed 2017·Application pending·0 cites
- 1362US2018207209A1Bifidobacteria for treating cardiac conditionsDUPONT NUTRITION BIOSCI APS·Filed 2018·Application pending·0 cites
- 1456US10543239B2Lactic acid bacteria and bifidobacteria for treating endotoxemiaDUPONT NUTRITION BIOSCI APS·Filed 2015·Granted Jan 28, 2020·0 cites·22 claims
- 1554US11285180B2Methods of enhancing the potency of incretin-based drugs in subjects in need thereofINST NAT SANTE RECH MED·Filed 2017·Granted Mar 29, 2022·0 cites·8 claims
- 1653US11684633B2Polydextrose for the prevention and/or treatment of heart failureVAIOMER·Filed 2021·Granted Jun 27, 2023·0 cites·16 claims
- 1753US2012107291A1Bifidobacteria for treating diabetes and related conditionsBURCELIN REMY·Filed 2010·Application pending·0 cites
- 1853US2022218768A1Methods of enhancing the potency of incretin-based drugs in subjects in need thereofINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 1952US2023338496A1Vaccination against diabetes, obesity and complications thereofINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 2044US10925951B2Vaccination against diabetes, obesity and complications thereofINST NAT SANTE RECH MED·Filed 2016·Granted Feb 23, 2021·0 cites·1 claims
- 2143US11623003B2Vaccination against diabetes, obesity and complications thereofINST NAT SANTE RECH MED·Filed 2020·Granted Apr 11, 2023·0 cites·10 claims
- 2241US2021100831A1Polydextrose for the treatment of inflammatory diseasesINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 2341US2011189149A1New Uses of Lactic Acid Bacteria and BifidobacteriaBURCELIN REMY·Filed 2008·Application pending·0 cites
- 2439US2018360867A1Polydextrose for the prevention and/or treatment of heart failureVAIOMER·Filed 2016·Application pending·0 cites
- 2538US2021393737A1Use of mam polypeptides for the treatment of obesity and obesity-related disordersINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 2633US2013029996A1Special composition for the use thereof as a drugBURCELIN REMY·Filed 2011·Application pending·0 cites
- 2733US2014086954A1Use of blood or tissue bacteriome for prediction, diagnosis and prevention of metabolic diseases and their cardiovascular complicationsBURCELIN REMY·Filed 2012·Application pending·0 cites
- 2833US2014186829A1Method for predicting insulinopenic type 2 diabetesBURCELIN REMY·Filed 2012·Application pending·0 cites
- 2933US2014088203A1Method for predicting abdominal obesityAMAR JACQUES·Filed 2012·Application pending·0 cites
- 3027US2012021421A1Bacterial DNA as Markers of Cardiovascular and/or Metabolic DiseaseAMAR JACQUES·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →